One shot to stop cancer: HPV vaccine study could change global prevention
NCT ID NCT05237947
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study tests whether a single dose of the HPV vaccine can protect young women aged 18-30 from cervical cancer. Researchers in Costa Rica are giving 5,000 women either one HPV shot or a placebo to see if one dose is enough to prevent persistent HPV infections that can lead to cancer. If successful, this could simplify vaccination programs worldwide.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Liberia, Guanacaste Province, 50101, Costa Rica
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New study aims to slash cervical cancer deaths in HIV-positive women
- HPV Vaccine's Long-Term effects under the microscope in costa rica
- MRI-Guided radiation: a sharper aim for HPV cancers?
- At-Home style HPV test at Walk-In clinics could boost cancer screening
- Could a Self-Collection kit in the ER help prevent cervical cancer?
- One-Shot wonder? huge study tests single HPV vaccine dose